$10.11
Insights on Enhabit Inc
Revenue is up for the last 2 quarters, 258.3M → 260.6M (in $), with an average increase of 0.9% per quarter
Netprofit is down for the last 2 quarters, -2.4M → -6.4M (in $), with an average decrease of 166.7% per quarter
In the last 1 year, Davita Healthcare Partners Inc. has given 52.9% return, outperforming this stock by 71.0%
0.79%
Downside
Day's Volatility :3.37%
Upside
2.6%
29.57%
Downside
52 Weeks Volatility :51.2%
Upside
30.71%
Period | Enhabit Inc | Index (Russel 2000) |
---|---|---|
3 Months | 0.49% | 0.0% |
6 Months | 24.97% | 0.0% |
1 Year | -18.06% | -1.5% |
3 Years | -55.32% | -21.8% |
Market Capitalization | 513.6M |
Book Value | $13.38 |
Earnings Per Share (EPS) | -1.61 |
Wall Street Target Price | 10.93 |
Profit Margin | -7.69% |
Operating Margin TTM | 1.88% |
Return On Assets TTM | 1.61% |
Return On Equity TTM | -10.7% |
Revenue TTM | 1.0B |
Revenue Per Share TTM | 20.97 |
Quarterly Revenue Growth YOY | -1.0% |
Gross Profit TTM | 545.5M |
EBITDA | 69.1M |
Diluted Eps TTM | -1.61 |
Quarterly Earnings Growth YOY | -0.9 |
EPS Estimate Current Year | 0.25 |
EPS Estimate Next Year | 0.31 |
EPS Estimate Current Quarter | 0.03 |
EPS Estimate Next Quarter | 0.04 |
What analysts predicted
Upside of 8.11%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | - |
Net Income | 24.0M | - |
Net Profit Margin | 2.2% | - |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 1.26% |
Net Income | 75.0M | ↑ 212.5% |
Net Profit Margin | 6.96% | ↑ 4.76% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↑ 2.63% |
Net Income | 111.1M | ↑ 48.13% |
Net Profit Margin | 10.04% | ↑ 3.08% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.1B | ↓ 2.12% |
Net Income | 62.5M | ↓ 43.74% |
Net Profit Margin | 5.77% | ↓ 4.27% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.0B | ↓ 3.4% |
Net Income | -80.5M | ↓ 228.8% |
Net Profit Margin | -7.69% | ↓ 13.46% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Revenue | 265.7M | ↓ 0.86% |
Net Income | 8.6M | ↓ 57.21% |
Net Profit Margin | 3.24% | ↓ 4.26% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Revenue | 275.1M | ↑ 3.54% |
Net Income | 7.7M | ↓ 10.47% |
Net Profit Margin | 2.8% | ↓ 0.44% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 265.1M | ↓ 3.64% |
Net Income | 2.7M | ↓ 64.94% |
Net Profit Margin | 1.02% | ↓ 1.78% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 262.3M | ↓ 1.06% |
Net Income | -74.4M | ↓ 2855.56% |
Net Profit Margin | -28.36% | ↓ 29.38% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 258.3M | ↓ 1.52% |
Net Income | -2.4M | ↓ 96.77% |
Net Profit Margin | -0.93% | ↑ 27.43% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 260.6M | ↑ 0.89% |
Net Income | -6.4M | ↑ 166.67% |
Net Profit Margin | -2.46% | ↓ 1.53% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | - |
Total Liabilities | 227.0M | - |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 1.7B | ↑ 6.38% |
Total Liabilities | 236.7M | ↑ 4.27% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 1.6B | ↓ 4.33% |
Total Liabilities | 767.3M | ↑ 224.17% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 1.5B | ↓ 10.89% |
Total Liabilities | 764.7M | ↓ 0.34% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 0.09% |
Total Liabilities | 108.0M | ↓ 85.89% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Total Assets | 1.6B | ↑ 1.4% |
Total Liabilities | 772.6M | ↑ 615.37% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↓ 7.21% |
Total Liabilities | 751.0M | ↓ 2.8% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.4B | ↓ 6.6% |
Total Liabilities | 719.0M | ↓ 4.26% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 1.73% |
Total Liabilities | 742.1M | ↑ 3.21% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 1.5B | ↑ 1.07% |
Total Liabilities | 764.7M | ↑ 3.05% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 59.5M | - |
Investing Cash Flow | -246.0M | - |
Financing Cash Flow | 198.2M | - |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.9M | ↓ 58.15% |
Investing Cash Flow | -3.0M | ↓ 98.78% |
Financing Cash Flow | -16.7M | ↓ 108.43% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 123.3M | ↑ 395.18% |
Investing Cash Flow | -119.2M | ↑ 3873.33% |
Financing Cash Flow | -36.1M | ↑ 116.17% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 80.1M | ↓ 35.04% |
Investing Cash Flow | -42.3M | ↓ 64.51% |
Financing Cash Flow | -18.6M | ↓ 48.48% |
Q3 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 1000.0K | ↓ 97.02% |
Investing Cash Flow | -600.0K | ↓ 71.43% |
Financing Cash Flow | -6.2M | ↓ 720.0% |
Q4 FY22 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 310.0% |
Investing Cash Flow | -38.2M | ↑ 6266.67% |
Financing Cash Flow | 13.4M | ↓ 316.13% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 4.1M | ↑ 0.0% |
Investing Cash Flow | -3.2M | ↓ 91.62% |
Financing Cash Flow | 13.4M | ↑ 0.0% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 9.6M | ↑ 134.15% |
Investing Cash Flow | -800.0K | ↓ 75.0% |
Financing Cash Flow | -11.9M | ↓ 188.81% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 6.3M | ↓ 34.37% |
Investing Cash Flow | -1.8M | ↑ 125.0% |
Financing Cash Flow | -5.8M | ↓ 51.26% |
Sell
Neutral
Buy
Enhabit Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Enhabit Inc | -7.3% | 24.97% | -18.06% | -55.32% | -55.32% |
Fresenius Medical Care Ag | -0.32% | 10.42% | -15.35% | -50.85% | -51.82% |
Hca Holdings, Inc. | -4.93% | 28.25% | 14.58% | 59.59% | 169.9% |
Tenet Healthcare Corp. | -4.36% | 72.26% | 44.71% | 82.68% | 310.08% |
Universal Health Services Inc. | -9.74% | 24.99% | 16.98% | 9.58% | 28.53% |
Davita Healthcare Partners Inc. | -6.85% | 62.1% | 52.88% | 15.22% | 144.38% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Enhabit Inc | 9.84 | NA | NA | 0.25 | -0.11 | 0.02 | NA | 13.38 |
Fresenius Medical Care Ag | 20.44 | 20.44 | 0.39 | 2.04 | 0.05 | 0.03 | 0.03 | 46.42 |
Hca Holdings, Inc. | 17.0 | 17.0 | 1.44 | 20.64 | 0.12 | 0.11 | 0.01 | -6.68 |
Tenet Healthcare Corp. | 17.21 | 17.21 | 2.2 | 6.03 | 0.26 | 0.06 | NA | 16.09 |
Universal Health Services Inc. | 16.27 | 16.27 | 1.87 | 13.45 | 0.12 | 0.05 | 0.0 | 91.53 |
Davita Healthcare Partners Inc. | 17.49 | 17.49 | 1.16 | 9.01 | 0.39 | 0.06 | NA | 11.89 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Enhabit Inc | Sell | $513.6M | -55.32% | 9.84 | -7.69% |
Fresenius Medical Care Ag | Hold | $10.9B | -51.82% | 20.44 | 2.57% |
Hca Holdings, Inc. | Buy | $85.3B | 169.9% | 17.0 | 8.07% |
Tenet Healthcare Corp. | Buy | $9.7B | 310.08% | 17.21 | 2.97% |
Universal Health Services Inc. | Hold | $11.2B | 28.53% | 16.27 | 5.03% |
Davita Healthcare Partners Inc. | Hold | $11.3B | 144.38% | 17.49 | 5.7% |
BlackRock Inc
Vanguard Group Inc
Deerfield Management Co
AREX CAPITAL MANAGEMENT, LP
Van Lanschot Kempen Investment Management NV
Jana Partners Management LP
Organization | Enhabit Inc |
Employees | 10800 |
CEO | Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T. |
Industry | Healthcare |